Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
46.8M
-
Shares change
-
+5.87M
-
Total reported value, excl. options
-
$1.35B
-
Value change
-
+$171M
-
Put/Call ratio
-
0.9
-
Number of buys
-
65
-
Number of sells
-
-23
-
Price
-
$28.93
Significant Holders of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) as of Q1 2021
102 filings reported holding ARQT - Arcutis Biotherapeutics, Inc. - Common Stock as of Q1 2021.
Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.8M shares
of 120M outstanding shares and own 38.99% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (10.5M shares), FMR LLC (7.64M shares), ORBIMED ADVISORS LLC (6.07M shares), BlackRock Inc. (4.2M shares), Bain Capital Life Sciences Investors, LLC (3.98M shares), Polar Capital Holdings Plc (1.56M shares), VANGUARD GROUP INC (1.53M shares), STATE STREET CORP (968K shares), Sectoral Asset Management Inc (879K shares), and WELLS FARGO & COMPANY/MN (877K shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.